BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art

SIMPLE SUMMARY: The BRCA genetic test and HRD (homologous recombination deficiency) test are used as a companion diagnosis before starting PARP (poly ADP-ribose polymerase) inhibitor treatment. In clinical practice, gynecologists treating ovarian cancer are faced with decisions such as whether to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekine, Masayuki, Nishino, Koji, Enomoto, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197088/
https://www.ncbi.nlm.nih.gov/pubmed/34071148
http://dx.doi.org/10.3390/cancers13112562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197088/
https://www.ncbi.nlm.nih.gov/pubmed/34071148
http://dx.doi.org/10.3390/cancers13112562

Ejemplares similares